Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults
- PMID: 32005532
- DOI: 10.1016/j.clnu.2020.01.005
Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults
Abstract
Background & aims: Clinical trials have reported controversial results regarding the effectiveness of probiotics in alleviating functional constipation in adults. We reviewed relevant randomized controlled trials to elucidate the effectiveness of probiotics on constipation symptoms in adults with functional constipation.
Methods: We searched Medline, the Cochrane Library, Web of Science, and Google Scholar for relevant articles published up to April 2019. The primary outcomes of interest were stool frequency, gut transit time (GTT), stool consistency, and bloating. Two authors independently performed the study selection, risk-of-bias assessment, and data extraction. The outcome data were extracted from each included study and synthesized using weighted mean differences (WMDs) or standardized mean differences (SMDs). Pooled data synthesis was performed using a random-effects model.
Results: In total, 2327 relevant studies were identified, 15 of which were found to be eligible randomized controlled trials and were included in the meta-analysis. Pooling of the extracted data demonstrated that probiotic consumption significantly reduced the whole GTT by 13.75 h [95% confidence interval (CI): -21.93 to -5.56 h] and increased the stool frequency by 0.98 (95% CI: 0.36 to 1.60) bowel movements per week. This increase was significant with the consumption of multispecies probiotics [at least two bacteria; WMD: 1.22 (95% CI: 0.50 to 1.94) bowel movements per week] but not with the consumption of Bifidobacterium lactis [WMD: 1.34 (95% CI: -0.27 to 2.94) bowel movements per week] or B. longum [WMD: -0.02 (95% CI: -0.56 to 0.53) bowel movements per week] alone. Multispecies probiotics (WMD: 1.37; 95% CI: 0.72 to 2.01), but not single-species probiotics (WMD: 1.18; 95% CI: -0.59 to 2.96), improved stool consistency (WMD: 1.30; 95% CI: 0.22 to 2.38). Similarly, multispecies probiotics (at least two bacteria; WMD: -0.49; 95% CI: -0.85 to -0.13), but not single-species probiotics (WMD: -0.24; 95% CI: -0.55 to 0.07), significantly decreased bloating. Performance bias were high, whereas detection bias was unclear because of inadequate reporting.
Conclusion: Consumption of probiotics, in particular, multispecies probiotics, may substantially reduce the GTT, increase the stool frequency, and improve the stool consistency. Thus, probiotics can be regarded as safe and natural agents for alleviation of functional constipation in adults.
Keywords: Adult; Clinical randomized trial; Constipation; Probiotic; meta-analysis.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare that they have no competing interests.
Similar articles
-
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.Am J Clin Nutr. 2014 Oct;100(4):1075-84. doi: 10.3945/ajcn.114.089151. Epub 2014 Aug 6. Am J Clin Nutr. 2014. PMID: 25099542 Review.
-
The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.Trials. 2018 Apr 27;19(1):256. doi: 10.1186/s13063-018-2648-x. Trials. 2018. PMID: 29703235 Free PMC article.
-
Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis.BMJ Open. 2024 Jan 18;14(1):e074557. doi: 10.1136/bmjopen-2023-074557. BMJ Open. 2024. PMID: 38238054 Free PMC article.
-
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.Gut Microbes. 2023 Jan-Dec;15(1):2197837. doi: 10.1080/19490976.2023.2197837. Gut Microbes. 2023. PMID: 37078654 Free PMC article. Clinical Trial.
-
Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials.World J Gastroenterol. 2013 Aug 7;19(29):4718-25. doi: 10.3748/wjg.v19.i29.4718. World J Gastroenterol. 2013. PMID: 23922468 Free PMC article. Review.
Cited by
-
Role of gut microbiota in functional constipation.Gastroenterol Rep (Oxf). 2021 Aug 6;9(5):392-401. doi: 10.1093/gastro/goab035. eCollection 2021 Oct. Gastroenterol Rep (Oxf). 2021. PMID: 34733524 Free PMC article. Review.
-
Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation.Nutrients. 2022 Sep 8;14(18):3704. doi: 10.3390/nu14183704. Nutrients. 2022. PMID: 36145079 Free PMC article. Review.
-
Characteristics of fecal microbiota in different constipation subtypes and association with colon physiology, lifestyle factors, and psychological status.Therap Adv Gastroenterol. 2023 Feb 27;16:17562848231154101. doi: 10.1177/17562848231154101. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36875281 Free PMC article.
-
Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review.Nutrients. 2022 Sep 9;14(18):3726. doi: 10.3390/nu14183726. Nutrients. 2022. PMID: 36145102 Free PMC article.
-
Supplementation with probiotics, prebiotics, and synbiotics in patients with chronic functional constipation: a randomized, double-blind, placebo-controlled pilot clinical trial.Gastroenterol Rep (Oxf). 2024 Nov 11;12:goae101. doi: 10.1093/gastro/goae101. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 39530075 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous